ArticleInternational journal of hematology-oncology and stem cell research2023
Assessment of Effectiveness and Adverse Effect of New Combination Chemotherapy (irinotecan, cisplatin, and dexamethasone) in Relapse and Refractory Hodgkin Lymphoma.
Mahdi Tabarraee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.